Literature DB >> 7709931

The economic and human costs of osteoporotic fracture.

E Barrett-Connor1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7709931     DOI： 10.1016/s0002-9343(05)80037-3

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  38 in total

1.  [Vertebroplasty in severe osteoporosis. Technique and experience with multi-segment injection].

Authors:  P F Heini; R Orler
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

2.  The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.

Authors:  Sunday A Shoyele; Neeraj Sivadas; Sally-Ann Cryan
Journal:  AAPS PharmSciTech       Date:  2011-01-27       Impact factor: 3.246

3.  Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis.

Authors:  Xin-Ying Tang; Nan Ru; Qing Li; Yang-Yang Qian; Hui Sun; Jia-Hui Zhu; Lin He; Yuan-Chen Wang; Liang-Hao Hu; Zhao-Shen Li; Wen-Bin Zou; Zhuan Liao
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

4.  Timeline of functional recovery after hip fracture in seniors aged 65 and older: a prospective observational analysis.

Authors:  K Fischer; M Trombik; G Freystätter; A Egli; R Theiler; H A Bischoff-Ferrari
Journal:  Osteoporos Int       Date:  2019-04-02       Impact factor: 4.507

5.  Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.

Authors:  J A Stakkestad; L I Benevolenskaya; J J Stepan; A Skag; A Nordby; E Oefjord; A Burdeska; I Jonkanski; P Mahoney
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

6.  Evaluation and management of osteoporosis following hospitalization for low-impact fracture.

Authors:  Christine Simonelli; Ya-Ting Chen; Julie Morancey; Anne F Lewis; Thomas A Abbott
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

7.  Lasofoxifene: Evidence of its therapeutic value in osteoporosis.

Authors:  Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Ranuccio Nuti
Journal:  Core Evid       Date:  2010-06-15

8.  Efficacy and cost-effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial.

Authors:  Caroline E Wyers; José J L Breedveld-Peters; Petronella L M Reijven; Svenjhalmar van Helden; Nick A Guldemond; Johan L Severens; Aart D Verburg; Berry Meesters; Lodewijk W van Rhijn; Pieter C Dagnelie
Journal:  BMC Public Health       Date:  2010-04-27       Impact factor: 3.295

9.  Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization.

Authors:  J A Sunyecz; L Mucha; O Baser; C E Barr; M M Amonkar
Journal:  Osteoporos Int       Date:  2008-03-20       Impact factor: 4.507

10.  Osteoporotic fractures and hospitalization risk in chronic spinal cord injury.

Authors:  L R Morse; R A Battaglino; K L Stolzmann; L D Hallett; A Waddimba; D Gagnon; A A Lazzari; E Garshick
Journal:  Osteoporos Int       Date:  2008-06-26       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.